Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ascletis Pharma Inc. Capital/Financing Update 2012

Nov 12, 2012

50081_rns_2012-11-12_aaaa02ba-5463-4ae7-b93f-8203abefd022.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [81 x 63] intentionally omitted <==

世 界 ( 集 團 ) 有 限 公 司 WORLD HOUSEWARE (HOLDINGS) LIMITED (Incorporated in the Cayman Islands with limited liability) (Stock Code: 713)

GRANT OF SHARE OPTIONS

This announcement is made pursuant to Rule 17.06A of the Rules Governing the Listing of Securities (the “Listing Rules”) on The Stock Exchange of Hong Kong Limited (the “Stock Exchange”).

The board of directors (the “Board”) of World Houseware (Holdings) Limited (the “Company”) announces that on 12 November 2012, the Company has granted 55,300,000 share options (the “Options”) to certain eligible participants (the “Grantees”) to subscribe for a total of 55,300,000 ordinary shares of HK$0.10 each (the “Shares”) of the Company under the share option scheme of the Company adopted on 10 June 2011. Details of the grant of the Options are set out as follows:

Date of grant : 12 November 2012

Exercise price of : HK$0.309 per Share (being by reference the highest of (i) the closing Options granted price of HK$0.305 per Share as stated in the Stock Exchange’s daily quotation sheet on the date of grant; (ii) the average closing price of HK$0.309 per Share as stated in the Stock Exchange’s daily quotation sheets for the five trading days immediately preceding the date of grant; and (iii) the nominal value of HK$0.10 per Share)

Number of Options : 55,300,000 Options

(each Option shall entitle the holder thereof to subscribe for one Share)

Closing market : HK$0.305 per Share price of the Shares on the date of grant

Validity period of : The Options shall be exercisable during the period of 10 years from the Options granted the date of grant, i.e. from 12 November 2012 to 11 November 2022

1

Among the Options granted above, 28,300,000 Options were granted to the directors with details as follows:

Name of GranteeLee Tat HingFung Mei Po Lee Chun SingLee Pak TungChan Lai Kuen AnitaCheung Tze Man EdwardTsui Chi Him SteveHui Chi Kuen ThomasHo Tak Kay Position Executive director (Chairman)Executive director(Vice Chairperson andChief Executive Officer)Executive director (Vice Chairman)Executive directorExecutive directorNon-executive directorIndependent non-executiveDirectorIndependent non-executiveDirectorIndependent non-executiveDirector Number of Options granted
6,500,0006,500,0006,500,0003,000,0003,000,0001,000,000600,000600,000600,000

Save as disclosed above, none of the Grantees is a director, chief executive or substantial shareholder of the Company, nor an associate (as defined in the Listing Rules) of any of them.

The grant of Share Options to the directors and chief executive of the Company has been approved by the independent non-executive directors in accordance with 17.04(1) of the Listing Rules.

By Order of the Board Lee Tat Hing Chairman

Hong Kong, 12 November 2012

As at the date of this announcement, the executive directors of the Company are Mr. Lee Tat Hing, Madam Fung Mei Po, Mr. Lee Chun Sing, Mr. Lee Pak Tung and Madam Chan Lai Kuen Anita; the non-executive director of the Company is Mr. Cheung Tze Man Edward; the independent non-executive directors of the Company are Mr. Tsui Chi Him Steve, Mr. Hui Chi Kuen Thomas, Mr. Ho Tak Kay and Mr. Shang Sze Ming.

2